NEW YORK – Myriad Genetics has implemented a new fetal DNA enrichment method for its Prequel noninvasive prenatal screening test that it hopes will further increase uptake of the test among clinicians and patients.
The improvement adds to various strategies providers of NIPT have used to enhance their offerings over the years, both on the technology side and regarding the data analysis.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
